If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.30
Bid: 40.15
Ask: 41.05
Change: 0.60 (1.47%)
Spread: 0.90 (2.242%)
Open: 40.05
High: 41.30
Low: 39.50
Prev. Close: 40.70
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

Tue, 06th Feb 2024 17:04

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

The FTSE 100 index ended up 68.15 points, 0.9%, at 7,681.01. London's large-cap index was on a four-day losing streak ahead of Tuesday's session.

The FTSE 250 ended 152.79 points higher, 0.8%, at 19,171.34, and the AIM All-Share rose 3.80 points, 0.5%, at 754.17.

The Cboe UK 100 shot up 1.1% at 769.35, the Cboe UK 250 added 1.0% at 16,613.67, but the Cboe Small Companies faded 0.3% to 14,638.59.

In mainland Europe, the CAC 40 in Paris rose 0.7%, while the DAX 40 in Frankfurt climbed 0.7%.

In New York, the Dow Jones Industrial Average was up 0.2% at the time of the closing bell in Europe. The S&P 500 was only marginally higher, while the Nasdaq Composite was a touch lower.

The European open received some impetus after bullish trade in Asia, on policy support measures to boost beleaguered shares. Stocks exposed to China were among the better performers in London, with Asia-focused insurer Prudential up 3.8%.

There was also some better data which bolstered sentiment in Europe. The European Central Bank said that median expectations for inflation over the next 12 months decreased as it published a consumer expectation survey from December.

Median expectations for inflation over the next 12 months eased to 3.2% in December from 3.5% in November. The ECB said that this was the third consecutive month of decline.

Meanwhile, new manufacturing orders in Germany unexpectedly rose in December, according to preliminary data, marking an improvement from the previous month for Europe's largest economy.

According to Destatis, factory orders rose by 8.9% on-month in December, after being stagnant from October to November. FXStreet were expecting factory orders to be stagnant.

In the UK, the downturn in the construction sector eased slightly at the start of the year, according to a survey.

The S&P Global UK construction purchasing managers' index rose to 48.8 points in January from 46.8 points in December. This marks the highest reading since August 2023 and is higher than FXStreet market consensus of 47.3 points.

That said, the index remained below the crucial 50.0 no-change threshold for the fifth month running.

The pound was quoted at USD1.2590 late Tuesday in London, higher compared to USD1.2527 at the equities close on Monday. The euro stood at USD1.0749, up slightly against USD1.0728. Against the yen, the dollar was trading at JPY148.09, lower compared to JPY148.80.

In London, BP shares shot up 5.3%.

XTB analyst Kathleen Brooks commented: "Although 2023 full year profits were shy of estimates, the strong Q4 performance suggests that the company gathered steam at the end of last year, which is a good backdrop for 2024's performance. There was good news on gas trading and its profitable convenience line, which saw gross margins soar, the company also jumped on the AI bandwagon."

BP said it completed its USD1.5 billion share buyback on Friday, and now intends to initiate a new USD1.75 billion buyback, prior to reporting its first quarter results which are due on May 7. It intends to buy back USD3.5 billion in shares for the first half of 2024.

BP added that it plans to conduct share buybacks worth at least USD14 billion through 2025, as part of its commitment to return at least 80% of surplus cash flow to shareholders.

In 2023, revenue dropped by 14% to USD213.03 billion from USD248.89 billion in 2022. However, pretax profit jumped by 54% to USD23.75 billion from USD15.41 billion.

Renishaw surged 16%.

The Gloucestershire, England-based provider of manufacturing technologies, analytical instruments and medical devices said pretax profit fell 27% to GBP56.5 million in the six months that ended December 31 from GBP77.8 million a year before.

Revenue declined 4.9% to GBP330.5 million from GBP347.7 million a year earlier.

Despite the weaker results, Renishaw left its dividend unchanged at 16.8 pence per share.

Looking ahead, Chief Executive Officer William Lee said: "We expect an improvement in our trading performance in the second half of the financial year as market conditions improve, and as we continue to pursue a range of growth opportunities. To support our through-cycle growth strategy, we are continuing to focus on productivity and to make targeted investments in our people, our production facilities, and our new product pipeline."

Elsewhere in London, Futura Medical shares jumped 40% as it hailed its first "meaningful" from product sales.

The Guildford, Surrey-based pharmaceutical company expects to report GBP3.1 million revenue for 2023. No revenue was recognised in 2022.

Chief Executive Officer James Barder said: "I am incredibly proud to report that we have delivered on the three key objectives that we set out in 2023: achieving regulatory approval in the US; progressing commercial discussions by securing a standout distribution partner in Haleon for the largest consumer healthcare market in the world and reporting our first meaningful revenues. The delivery of this progress, alongside the fact that we have an award-winning product, has given us a robust and broad platform to build upon in the year ahead."

Aston Martin Lagonda shares fell 3.9%.

News of seven-time Formula One world champion Lewis Hamilton's switch to Ferrari from Mercedes dominated automotive space chatter last week. Aston Martin Lagonda, is sizing up a personnel change of its own, according to Bloomberg.

A Bloomberg report said Executive Chair Lawrence Stroll has contacted current and former heads of other luxury auto manufacturers to gauge interest in the role, citing people familiar with the matter.

It would mark the fourth change in CEO at the luxury car manufacturer in as many years.

Stroll tapped Felisa, formerly the boss of Ferrari between 2008 and 2016, to be CEO in May 2022. He replaced former Mercedes-AMG boss Tobias Moers, who spent less than two years in the job. His predecessor, Andy Palmer, left months after Stroll rescued Aston Martin in early 2020.

Brent oil was quoted at USD78.57 a barrel at the time of the London equities close on Tuesday, up from USD77.11 late Monday. Gold traded at USD2,036.43 an ounce against USD2,019.86.

Wednesday's economic calendar has a Halifax UK house price index reading and German industrial production data at 0700 GMT.

In the local corporate calendar, housebuilder Barratt Developments and emerging markets-focused asset manager Ashmore release half-year results. Packaging firm Smurfit Kappa reports annual results.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
18 Jun 2018 13:25

European Wealth Appoints Jonathan Freeman As Non-Executive Director

LONDON (Alliance News) - European Wealth Group Ltd said Monday it appointed Jonathan Freeman as non-executive director.Freeman currently holds the roles of non-executive chairman of LED of

Read more
13 Jun 2018 12:36

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.In

Read more
26 Apr 2018 13:53

Futura Medical Begins Groundwork For MED 2002 Phase III Trial

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Thursday it has started preparing for a phase III trial for its proposed erectile dysfunction gel MED 2002.This trial what a

Read more
14 Mar 2018 16:08

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC said Wednesday that planned increase in research and development expenditure for the development of erectile dysfunction gel has in

Read more
10 Jan 2017 11:05

Futura Medical signs license agreement with Thornton & Ross

(ShareCast News) - Futura Medical, an AIM listed innovative healthcare company focused on transdermal technology, has signed a licensing agreement with Thornton & Ross for the commercialisation of TPR100, the company's novel diclofenac gel for pain relief. Thornton & Ross (T&R) is one of the largest

Read more
16 Nov 2016 09:28

Futura To Develop Two Dose Strengths Of Erectile Dysfunction Gel

Read more
27 Oct 2016 14:24

Futura Medical partner approved for erectogenic condom manufacture

(ShareCast News) - Advanced transdermal technology-focused healthcare company Futura Medical announced on Thursday that, as anticipated, its regulatory submission to allow TTK Protective Devices to manufacture its erectogenic condom, CSD500, has been approved by the relevant EU Notified Body with an

Read more
27 Oct 2016 08:11

Futura Medical To Raise Up To GBP12 Million To Speed Up Products (ALLISS)

Read more
7 Sep 2016 10:35

Futura Medical perks up on 'breakthrough' erectile dysfunction study

(ShareCast News) - Shares in AIM-listed Futura Medical perked up to a two-year high as the company revealed that trials of its erectile dysfunction (ED) treatment had found it to be effective, safe and with the potential to be the fastest-acting product on the market. A clinical study of Futura's ME

Read more
7 Sep 2016 07:25

LONDON BRIEFING: Change At Top For Well-Performing Hargreaves Lansdown

Read more
7 Sep 2016 07:11

Futura Medical Gets Positive Results On Erectile Dysfunction Gel

Read more
21 Jun 2016 07:11

Futura Medical Sees "Clear Potential For Value Generation This Year"

Read more
20 Jun 2016 07:26

Futura Medical Signs Southeast Europe Distribution Deal For Condom

Read more
14 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Jun 2016 10:13

Futura Signs Manufacturing And Indian Distribution Deal For New Condom

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.